Previous Article | Next Article ![]()
Appl. Environ. Microbiol., Nov 1996, 4086-4094, Vol 62, No. 11
DG Bourne, GJ Jones, RL Blakeley, A Jones, AP Negri and P Riddles
An isolated bacterium, identified as a new Sphingomonas species, was
demonstrated to contain a novel enzymatic pathway which acted on
microcystin LR, the most common cyanobacterial cyclic peptide toxin.
Degradation of microcystin LR was mediated by at least three intracellular
hydrolytic enzymes. The use of classic protease inhibitors allowed (i) the
classification of these enzymes into general protease families and (ii) the
in vitro accumulation of otherwise transient microcystin LR degradation
products. The initial site of hydrolytic cleavage of the parent cyclic
peptide by an enzyme that we designate microcystinase is at the
3-amino-9-methoxy-2,6,8-trimethyl-10- phenyl-deca-4,6-dienoic acid
(Adda)-Arg peptide bond. Two intermediates of microcystin LR enzymatic
degradation have been identified; one is linearized (acyclo-) microcystin
LR, NH2-Adda-Glu(iso)- methyldehydroalanine-Ala-Leu-beta-methylas
partate-Arg-OH, and the other is the tetrapeptide
NH2-Adda-Glu(iso)-methyldehydroalanine-Ala- OH. The intermediate
degradation products were less active than the parent cyclic peptide; the
observed 50% inhibitory concentrations for crude chicken brain protein
phosphatase were 0.6 nM for microcystin LR, 95 nM for linear LR, and 12 nM
for the tetrapeptide. These linear peptides were nontoxic to mice at doses
up to 250 micrograms/kg. Ring opening of the potent hepatotoxin microcystin
LR by bacterial microcystinase effectively renders the compound nontoxic by
dramatically reducing the interaction with the target protein phosphatase.
Enzymatic pathway for the bacterial degradation of the cyanobacterial cyclic peptide toxin microcystin LR
Department of Biochemistry, University of Queensland, St. Lucia, Australia.
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|